Nanobiotix S.A. American Depositary Shares (NBTX)
NASDAQ
Closed
Aug 25, 2026
Day's Range
40.1352 wk Range
8.03Overview - NBTX - Nanobiotix S.A. American Depositary Shares
Key Statistics
Valuation
Enterprise Value
2.51B
P/E (Trailing)
‪-79.54‬
P/E (Forward)
‪-127.11‬
PEG Ratio
‪-127.11‬
Price / Sales (TTM)
‪67.88‬
EV / EBITDA
‪-204.96‬
Profitability
Profit Margin
‪-73.51%‬
Operating Margin
‪-196.42%‬
Return on Assets
‪-10.06%‬
Return on Equity
‪28.36%‬
Ownership
Shares Outstanding
48.38M
Float
31.94M
Short % of Shares Outstanding
‪0.27%‬
Held by Insiders
‪0.00%‬
Held by Institutions
‪11.95%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪38.56‬
200-Day Avg
‪31.18‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - NBTX - Nanobiotix S.A. American Depositary Shares
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- NBTXNASDAQNanobiotix S.A. American Depositary Shares2.21BMarket Cap+77.38%52-week change-87.52P/E (Trailing)‪-73.51%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt62.93BMarket Cap+33.08%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.58BMarket Cap-87.93%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+23.98%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.84BMarket Cap+39.72%52-week change-21.44P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.27P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - NBTX - Nanobiotix S.A. American Depositary Shares
About
Nanobiotix S.A. is a pioneering biotechnology company focusing on developing innovative solutions for the treatment of cancer through nanomedicine. It primarily seeks to enhance the efficacy of existing radiotherapy methods, offering a higher precision level in targeting cancer cells while minimizing damage to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
